MD3527F1 - Metoda de inducere a parodontitei - Google Patents

Metoda de inducere a parodontitei

Info

Publication number
MD3527F1
MD3527F1 MDA20070127A MD20070127A MD3527F1 MD 3527 F1 MD3527 F1 MD 3527F1 MD A20070127 A MDA20070127 A MD A20070127A MD 20070127 A MD20070127 A MD 20070127A MD 3527 F1 MD3527 F1 MD 3527F1
Authority
MD
Moldova
Prior art keywords
ammonium chloride
broth
induction
water
diethildithiocarbamate
Prior art date
Application number
MDA20070127A
Other languages
English (en)
Other versions
MD3527G2 (ro
Inventor
Gheorghe GRANCIUC
Valentin Gudumac
Ion NASTAS
Original Assignee
Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova filed Critical Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova
Priority to MDA20070127A priority Critical patent/MD3527G2/ro
Publication of MD3527F1 publication Critical patent/MD3527F1/ro
Publication of MD3527G2 publication Critical patent/MD3527G2/ro

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Inventia se refera la medicina experimentala si poate fi utilizata pentru inducerea proceselor patologice in parodontiu, cercetarea patogenezei maladiei, elaborarea metodelor de tratament si monitorizarea eficacitatii lor. Esenta inventiei consta inadministrarea animalului de laborator per os, zilnic, in doza de 100 ml/kg de masa corporala, timpde 4 saptamani a unui amestec ce contine clorura de amoniu, dietilditiocarbamat de sodiu, zaharoza,bulion de vita si apa distilata in urmatorul raport al componentelor, la 100 ml: clorura de amoniu, g 2,5…3,5dietilditiocarbamat de sodiu, g 0,01…0,02 zaharoza, g 14,0…18,0 bulion de vita, g 10,0…15,0apa distilata, ml restul.
MDA20070127A 2007-05-03 2007-05-03 Metodă de inducere a parodontitei MD3527G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20070127A MD3527G2 (ro) 2007-05-03 2007-05-03 Metodă de inducere a parodontitei

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20070127A MD3527G2 (ro) 2007-05-03 2007-05-03 Metodă de inducere a parodontitei

Publications (2)

Publication Number Publication Date
MD3527F1 true MD3527F1 (ro) 2008-03-31
MD3527G2 MD3527G2 (ro) 2008-10-31

Family

ID=39271499

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20070127A MD3527G2 (ro) 2007-05-03 2007-05-03 Metodă de inducere a parodontitei

Country Status (1)

Country Link
MD (1) MD3527G2 (ro)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1399807A1 (ru) * 1985-05-23 1988-05-30 Одесский научно-исследовательский институт стоматологии Способ моделировани пародонтита

Also Published As

Publication number Publication date
MD3527G2 (ro) 2008-10-31

Similar Documents

Publication Publication Date Title
BRPI0411241A (pt) agentes terapêuticos úteis para o tratamento de dor
NI201100147A (es) Métodos para tratar infartos agudos de miocardio y trastornos relacionados.
MX2009011755A (es) Terapia de combinacion con un compuesto que actua como un inhibidor del receptor adp de plaquetas.
NZ595526A (en) Pharmaceutical composition comprising a vla-4 binding antibody, a phosphate buffer and a surfactant
UA99094C2 (ru) Способ лечения пациента с системной красной волчанкой
NZ597378A (en) Treatment of multiple sclerosis with laquinimod
BR0011823A (pt) Derivado de benzimidazol, composto, composição farmacêutica, uso de um derivado de benzimidazol, e, método para tratamento, prevenção ou alìvio de uma doença ou de um distúrbio ou de uma condição de um corpo animal vivo
BR0314943A (pt) Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes
SG155958A1 (en) Aryl-substituted piperazine derivatives
FR2903107B1 (fr) Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
TNSN07419A1 (en) Methods for treating drug resistant cancer
RU2008134874A (ru) Способ увеличения сухой мышечной массы и уменьшения жировой ткани
MXPA05013856A (es) Agonistas del receptor sht2c para el tratamiento de diabetes y obesidad.
WO2012044783A8 (en) Method of achieving a thymosin beta 4 concentration in a human patient
TW200635925A (en) Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents
MD3527F1 (ro) Metoda de inducere a parodontitei
EA200700176A1 (ru) Пептид, нормализующий метаболизм в костной и хрящевой тканях, фармацевтическая композиция на его основе и способ ее применения
NZ595798A (en) Ectoparasiticidal methods and formulations
MX2009006670A (es) Composicion farmaceutica que usa el aliskiren y el avosentan.
JP2005506959A5 (ro)
RU2007100833A (ru) Способ лечения инфекционной невропатии лицевого нерва в остром периоде
RU2010134265A (ru) Способ лечения диспепсии у телят
EA200801957A1 (ru) Способ повышения адаптивности организма к физическим нагрузкам
RU2000103102A (ru) Способ моделирования токсической гепатопатии
UA29235U (ru) Способ повышения производительности и стресcоустойчивости поросят

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees